Cargando…
Prediction of Targets of Curculigoside A in Osteoporosis and Rheumatoid Arthritis Using Network Pharmacology and Experimental Verification
PURPOSE: Network pharmacology is considered to be the next-generation drug development model that uses bioinformatics to predict and identify multiple drug targets and interactions in diseases. Here, network pharmacology was used to investigate the mechanism by which Curculigoside A (CA) acts in rhe...
Autores principales: | Han, Jiawen, Wan, Minjie, Ma, Zhanchuan, Hu, Cong, Yi, Huanfa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705647/ https://www.ncbi.nlm.nih.gov/pubmed/33273808 http://dx.doi.org/10.2147/DDDT.S282112 |
Ejemplares similares
-
Regulation of DNA‐PK activity promotes the progression of TNBC via enhancing the immunosuppressive function of myeloid‐derived suppressor cells
por: Han, Jiawen, et al.
Publicado: (2022) -
Curculigoside promotes osteogenic differentiation of ADSCs to prevent ovariectomized-induced osteoporosis
por: You, Wei-Li, et al.
Publicado: (2021) -
Network pharmacology analysis and clinical verification of Jishe Qushi capsules in rheumatoid arthritis treatment
por: Li, Yujie, et al.
Publicado: (2023) -
Mechanism and Experimental Verification of Luteolin for the Treatment of Osteoporosis Based on Network Pharmacology
por: Liang, Guihong, et al.
Publicado: (2022) -
The effect of curculigoside on mouse model of perimenopausal depression
por: Miao, Mingsan, et al.
Publicado: (2017)